GENINCODE PLC LS -01
Research GENINCODE PLC LS -01 (9PL) on Bullrun: market cap EUR 5.65M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker9PL
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 5.65M
- Financial periodFY2025
- RevenueGBP 3.08M
- Revenue growth13.9%
- Net income-GBP 5.71M
- Free cash flow-GBP 4.17M
- Gross margin58.6%
Valuation Snapshot
latest market cap is EUR 5.65M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 3.08M | -GBP 5.71M | -GBP 4.17M | 58.6% | -0.02 | GBP 827.00K | GBP 146.00K | GBP 124.00K |
| FY2024 | GBP 2.70M | -GBP 4.43M | -GBP 5.22M | 52.8% | -0.03 | GBP 1.11M | GBP 234.00K | GBP 1.13M |
| FY2023 | GBP 2.16M | -GBP 7.02M | -GBP 7.54M | 47.3% | -0.07 | GBP 2.48M | GBP 299.00K | GBP 1.29M |
| FY2022 | GBP 1.43M | -GBP 5.56M | -GBP 4.57M | 44.2% | -0.06 | GBP 9.73M | GBP 354.00K | GBP 7.90M |
| FY2021 | GBP 1.15M | -GBP 4.14M | -GBP 3.24M | 51.4% | -0.08 | GBP 14.55M | GBP 0 | GBP 13.72M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 5.65M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About GENINCODE PLC LS -01
GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient's health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test to evaluate the risk of coronary heart disease; LIPID inCode, a genetic test for the diagnosis of familial hypercholesterolemia with further coronary risk stratification of the patient;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GENINCODE PLC LS -01's market cap?
GENINCODE PLC LS -01's market capitalization is EUR 5.65M.
What does GENINCODE PLC LS -01 do?
GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient's health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally.